Christiane Copie‐Bergman

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Christiane Copie‐Bergman, Peggy Cuillière-Dartigues, Maryse Baia et al. · Blood · 2015 · 254 citations · Full text

Life Sciences, Immunology, Oncology +12

Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

Andreas Rosenwald, Susanne Bens, Ranjana H. Advani et al. · Journal of Clinical Oncology · 2019 · 254 citations · Full text

Medicine, Hematology, Oncology +17

Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL)

Jehan Dupuis, K. Boye, Nadine Martin et al. · The American Journal of Surgical Pathology · 2006 · 231 citations

Medicine, Oncology, Pathology +14

Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study

Emanuele Zucca, Annarita Conconi, Daniele Laszlò et al. · Journal of Clinical Oncology · 2013 · 226 citations

Medicine, Oncology, Pharmacotherapy +9

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

Camille Laurent, Marine Baron, Nadia Amara et al. · Journal of Clinical Oncology · 2017 · 217 citations

Medicine, Oncology, Pathology +17